Cargando…

Soluble MOG35-55/I-A(b) Dimers Ameliorate Experimental Autoimmune Encephalomyelitis by Reducing Encephalitogenic T Cells

The MOG35-55 peptide-induced experimental autoimmune encephalomyelitis (EAE) model in C57BL/6 mice is a useful animal model to explore therapeutic approaches to T cell-mediated autoimmune diseases because the dominant T-cell epitope(s) have been defined. It is rational that antigen-specific immunosu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Yeli, Wang, Zhigang, Liang, Zhihui, Duan, Hongxia, Ouyang, Lichen, Yu, Qian, Xu, Zhe, Shen, Guanxin, Weng, Xiufang, Wu, Xiongwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471819/ https://www.ncbi.nlm.nih.gov/pubmed/23077616 http://dx.doi.org/10.1371/journal.pone.0047435

Ejemplares similares

Myelin oligodendrocyte glycoprotein (MOG(35-55))-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice
por: Yun, Jaesuk, et al.
Publicado: (2015)

Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide
por: Buerth, Christoph, et al.
Publicado: (2016)

Characterization of myelin oligodendrocyte glycoprotein (MOG)(35–55)-specific CD8(+) T cells in experimental autoimmune encephalomyelitis
por: Peng, Yong, et al.
Publicado: (2019)

Arg Deficiency Does not Influence the Course of Myelin Oligodendrocyte Glycoprotein (MOG35-55)-induced Experimental Autoimmune Encephalomyelitis
por: Jacobsen, Freja Aksel, et al.
Publicado: (2016)

Myelin Oligodendrocyte Glycoprotein (MOG(35-55)) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
por: Bittner, Stefan, et al.
Publicado: (2014)

Active induction of experimental autoimmune encephalomyelitis by MOG(35-55) peptide immunization is associated with differential responses in separate compartments of the choroid plexus
por: Murugesan, Nivetha, et al.
Publicado: (2012)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG(35-55)-induced experimental autoimmune encephalomyelitis
por: Wetzel, Lisa A., et al.
Publicado: (2020)

Activation and Functional Alteration of Mucosal-Associated Invariant T Cells in Adult Patients With Community-Acquired Pneumonia
por: Ouyang, Lichen, et al.
Publicado: (2021)

Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG(35‐55)‐induced EAE through ERK and Akt signalling
por: Kamali, Salar, et al.
Publicado: (2021)

Neurons promote encephalitogenic CD4(+) lymphocyte infiltration in experimental autoimmune encephalomyelitis
por: Nakazato, Yuki, et al.
Publicado: (2020)

Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG(35–55)-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice
por: Zhang, Lanfang, et al.
Publicado: (2015)

HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
por: Benedek, Gil, et al.
Publicado: (2015)

Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells
Publicado: (1992)

Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions
por: Dagkonaki, Anastasia, et al.
Publicado: (2020)

Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG(35-55)-Induced EAE
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
por: Spadaro, Melania, et al.
Publicado: (2015)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
por: Jarius, S., et al.
Publicado: (2018)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
por: Kwon, Young Nam, et al.
Publicado: (2019)

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)

SUPPRESSION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN GUINEA PIGS BY ENCEPHALITOGENIC PROTEINS EXTRACTED FROM HOMOLOGOUS BRAIN
por: Shaw, Cheng-Mei, et al.
Publicado: (1960)

Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques
por: Fovet, Claire-Maëlle, et al.
Publicado: (2019)

The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis
por: Cravens, Petra D, et al.
Publicado: (2013)

Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide
Publicado: (1993)

Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
por: Chiuso-Minicucci, Fernanda, et al.
Publicado: (2015)

Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats
por: Kim, Ji-Youn, et al.
Publicado: (2020)

Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis
por: Remlinger, Jana, et al.
Publicado: (2022)

Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis
por: Yang, Xiaoming, et al.
Publicado: (2019)

Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
Publicado: (2015)

Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
por: das Neves, Sofia P., et al.
Publicado: (2018)

T(H) Cells and Cytokines in Encephalitogenic Disorders
por: Krishnarajah, Sinduya, et al.
Publicado: (2022)

Photobiomodulation Induced by 670 nm Light Ameliorates MOG35-55 Induced EAE in Female C57BL/6 Mice: A Role for Remediation of Nitrosative Stress
por: Muili, Kamaldeen A., et al.
Publicado: (2013)

AZD-1222: Acute disseminated encephalomyelitis anti-MOG antibody‑positive: case report
Publicado: (2022)

Clinical, radiological, therapeutic and prognostic differences between MOG-seropositive and MOG-seronegative pediatric acute disseminated encephalomyelitis patients: a retrospective cohort study
por: Dong, Xueshan, et al.
Publicado: (2023)

Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2017)

Cellular immunity to encephalitogenic peptide in tumour-bearing mice.
por: Yong, W. K., et al.
Publicado: (1982)

Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells
por: Mannara, Francesco, et al.
Publicado: (2012)

Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis
por: Cai, Yuanhua, et al.
Publicado: (2022)

IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis
por: Choi, Jin Kyeong, et al.
Publicado: (2017)

Encephalitogenicity of myelin basic protein exon-2 peptide in mice
por: Fritz, Robert B., et al.
Publicado: (1994)

MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated
por: Flytzani, Sevasti, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_52c2db33m6kmvngq4uj5pg30i1